Skip to content
A recent letter to U.S. Health and Human Services Secretary Xavier Becerra explains why a petition asking the government to “march in” on a […]
100 experts urge HHS to reject Bayh-Dole ‘march-in’ petition Read More »
Legislation to modernize the clinical drug development paradigm should be patient-centric, effective and inclusive, Biotechnology Innovation Organization (BIO) Chief Scientific Officer Dr. Cartier Esham
BIO’s CSO testifies at congressional hearing on PDUFA riders Read More »
The Senate Finance Committee held a hearing yesterday on “prescription drug price inflation,” during which witnesses testified that price controls would limit biotechnology innovation
Experts tell Senate drug price controls interfere with innovation, R&D Read More »
An opinion piece in the San-Jose Mercury News argues against forcing drug makers to allow for generic versions of their products simply because their
Other Voices: ‘Don’t sacrifice the miracle of American innovation’ Read More »
Bacterial and fungal infections that follow on the back of SARS-CoV-2 coronavirus have forced doctors to increase the use of antibiotics and antifungal medications,
Squash Superbugs Day of Action to address medical and market challenges of AMR Read More »
Much of the Russian oil that America has decided to forgo would be replaced with biofuels under the Home Front Energy Independence Act, unveiled
Bipartisan bill would replace banned Russian oil with biofuel Read More »
One of the first public statements made by Dr. Robert Califf after he was appointed as the new head of the U.S. Food and
FDA commissioner puts One Health on his agenda Read More »
In its input to the federal government’s report card on global respect for intellectual property (IP), the Biotechnology Innovation Organization (BIO) explains the importance
BIO gives input on federal report card on global respect for IP Read More »
President Biden on Feb. 2 relaunched the “Cancer Moonshot,” which he had launched when he was vice president. The goal now is to “reduce
Biden’s Cancer Moonshot aims to reduce death rate by 50% Read More »
The Food and Drug Administration (FDA) announced two decisions last week to allow for the use of remdesivir in certain adult and pediatric patients,
FDA approves remdesivir for COVID-19 patients, even before hospitalization Read More »
